Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor Xa Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00353678
What this trial is testing

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

Who this might be right for
Thromboembolism
Astellas Pharma Inc 1,141
Testing effectiveness (Phase 2)Study completedNCT00252005
What this trial is testing

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study

Who this might be right for
Deep-Vein Thrombosis
Bristol-Myers Squibb 520
Large-scale testing (Phase 3)Study completedNCT00942435
What this trial is testing

Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 156
Large-scale testing (Phase 3)Study completedNCT05185804
What this trial is testing

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Who this might be right for
COVID-19Venous Thromboembolism
PharmaDiall Ltd. 399
Testing effectiveness (Phase 2)Study completedNCT01203072
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisTotal Knee Arthroplasty
Daiichi Sankyo Co., Ltd. 523
Post-approval studies (Phase 4)Looking for participantsNCT06873321
What this trial is testing

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Who this might be right for
Peripheral Arterial DiseaseVenous ThormboembolismCardiovascular Diseases+1 more
Science Valley Research Institute 100
Testing effectiveness (Phase 2)Study completedNCT00448214
What this trial is testing

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 448
Early research (Phase 1)Looking for participantsNCT04874428
What this trial is testing

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Insel Gruppe AG, University Hospital Bern 24
Not applicableUnknownNCT06383741
What this trial is testing

Predicting Outcomes in ICH Patients on Direct Factor Xa Inhibitors

Who this might be right for
Intra Cerebral Hemorrhage
Insel Gruppe AG, University Hospital Bern 200
Testing effectiveness (Phase 2)Study completedNCT00742859
What this trial is testing

Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin

Who this might be right for
Atrial Fibrillation
Portola Pharmaceuticals 508
Testing effectiveness (Phase 2)Study completedNCT03088358
What this trial is testing

Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

Who this might be right for
Total Knee Replacement
TeaRx LLC 200
Early research (Phase 1)Study completedNCT02270918
What this trial is testing

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Who this might be right for
Thrombosis
Thomas Jefferson University 12
Testing effectiveness (Phase 2)Study completedNCT00375609
What this trial is testing

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Who this might be right for
Thromboembolism
Portola Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT05122455
What this trial is testing

Effects of Edoxaban on Platelet Aggregation

Who this might be right for
SCADAMI
University of Sao Paulo 61
Early research (Phase 1)UnknownNCT04036656
What this trial is testing

Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers

Who this might be right for
Venous Thrombosis
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 56
Testing effectiveness (Phase 2)Study completedNCT00641732
What this trial is testing

Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

Who this might be right for
Venous Thromboembolism
Takeda 1,045
Testing effectiveness (Phase 2)WithdrawnNCT00541320
What this trial is testing

Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)

Who this might be right for
Venous Thromboembolism
GlaxoSmithKline
Large-scale testing (Phase 3)Looking for participantsNCT05156983
What this trial is testing

TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Who this might be right for
Coagulation Disorder
Takeda 440
Testing effectiveness (Phase 2)Study completedNCT00973245
What this trial is testing

BAY59-7939 in Atrial Fibrillation Once Daily (OD)

Who this might be right for
Atrial Fibrillation
Bayer 102
Post-approval studies (Phase 4)Study completedNCT02672709
What this trial is testing

Apixaban in Hemodialysis

Who this might be right for
End-stage Renal Disease
Jewish General Hospital 7
Next Page